- Rottmann S, Wang Y, Nasoff M, Deveraux QL, Quon KC. A TRAIL receptor-dependent synthetic lethal relationship between MYC activation and GSK3beta/FBW7 loss of function. Proc Natl Acad Sci U S A 2005;102(42):15195-200.
- Cohen SB, Gaskins C, Nasoff MS. Generation of a monoclonal antibody agonist to toll-like receptor 4. Hybridoma (Larchmt) 2005;24(1):27-35.
- Wang Y, Engels IH, Knee DA, Nasoff M, Deveraux QL, Quon KC. Synthetic lethal targeting of MYC by activation of the DR5 death receptor pathway. Cancer Cell 2004;5(5):501-12.
- Ren YG, Wagner KW, Knee DA, Aza-Blanc P, Nasoff M, Deveraux QL. Differential regulation of the TRAIL death receptors DR4 and DR5 by the signal recognition particle. Mol Biol Cell 2004;15(11):5064-74.
- Wagner KW, King F, Nomoto K, Knee DA, Hampton G, Nasoff M, Deveraux QL. Activation and suppression of the TRAIL death-receptor pathway in chemotherapy sensitive and resistant follicular lymphoma cells. Cancer Biol Ther 2003;2(5):534-40.
- Nasoff M, Bergseid M, Hoeffler JP, Heyman JA. High-throughput expression of fusion proteins. Methods Enzymol 2000;328:515-29.
